The birth, in France, of its first baby to be conceived by artificial insemination on top of the selection of an embryo based on its blood, has sent new flames into the hot parliamentary debate over the reform of bioethics law.
Southampton University Hospitals’ Department of Laboratory Medicine has recently transformed the way it delivers its pathology service, becoming one of the largest automation installations in the National Health Service to operate under a managed service contract. This has contributed significantly to the development of a strengthened and expanded pathology network across Southern England.
Although paediatric laboratory medicine and clinical chemistry is a well and long established scientific field, it is still a challenging one with its own special problems, as Dr Massimiliano Cantinotti, Paediatric Cardiologist Consultant at Fondazione G Monasterio, National Research Institute, Massa, Italy, well knows.
The smaller the child, the more defenceless it is against viral and bacterial attacks. That is why infection accompanied by the symptom of a high temperature is the most common illness in children. So, when a child has a runny nose and fever an infection is clear. The more elemental question is: Should it be treated with antibiotics?
1-2 April 2011 – time for lab and clinical staff to be in Parma, Italy, at the 1st European Conference on Pre-analytical Phase. Organised by the European Federation of Clinical Chemistry and Laboratory Medicine (EFCC), the meeting will meeting present a range of events to launch a platform for continuous knowledge and idea exchanges regarding pre-analytical aspects of lab medicine.
USA - Over the past couple of decades, due to acquisitions California-based Beckman Coulter Inc has became one of the world’s largest manufacturers of in vitro diagnostics analysers and automation for clinical pathology laboratories. Now, in a US$6.8 billion transaction, including debt and cash acquired, the company itself been acquired by the Danaher Corporation of Washington, D.C.
The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein biomarkers in exhaled air divulge the presence of pathological cells in the lung.
The trend towards personalised medicine implies the development of targeted cancer therapy. Tissue based examinations by pathologists play a key role in this trend. However, the relevance is still underestimated as pathologist Professor Manfred Dietel noted in his lecture at the European Forum on Oncology 2010 in Berlin, which explained what pathology already actually renders to targeted cancer…
Improvements in microfluidics and detection technologies are beginning to expand the range of point-of-care diagnostics beyond simple blood chemistry tests to sophisticated immuno-assays and molecular diagnostics. Though yet to see much adoption in European hospitals, these point-of-care (POC) diagnostics are coming into use in the USA, initially in emergency rooms and ICUs where fast results are…
The world consists of molecules – so do we. With the progression of measurement tools such as microscopes, centrifuges, or spectrometers, mankind is becoming better and better in identifying the substances from which our world is made. Today, with the technical developments in mass spectrometry, biomolecules can be weighted with the highest precision and accuracy ever known, placing it among…
For some time, German pathology has only been in the background of the medical disciplines. However, during the last ten years the profession stepped up to the fore. In the face of molecular medicine developments, the German Association of Pathologists redefined its members position with revived self-confidence.
Different tests bring different results, and results of the same types of test vary from laboratory to laboratory. "In the case of test procedures for autoimmune diseases there are incredible discrepancies," confirmed Professor Manfred Herold, head of the Laboratory for Rheumatism at the University Clinic for Internal Medicine One, Innsbruck. The reason: "There are no standards for…
Bedside testing of parameters has been introduced in clinical practice much earlier than laboratory testing: In past centuries, not only were temperature or pulse rate taken at the point of care (POC), but also qualitative blood or urine analysis were performed right next to a patient’s bed
With its initial launch at the start of 2010, the Xplorer® electronic pipette has already been awarded 3 design prizes in its first year on the market. Immediately following its market launch in March 2010, the Xplorer won the "red dot: best of the best" award in the product design 2010 category (Life science and medicine division).
Students and teaching staff expressed difficulty in defining professionalism in pharmacy clearly and succintly. For most it seems to more an implicit than explicit concept, ie "you know it when you see it" according to a study undertaken in UK schools of pharmacy.
Cancer stem cells (CSCs) are the engine that drives tumour growth. They can not only reproduce themselves but also differentiate to form all the specialised cells found within a tumour. While chemotherapy and radiotherapy non-specifically target all rapidly dividing cells, there is increasing evidence that CSCs are more resistant to these treatments. Report: Karoline Laarmann
Used in conjunction with clinical assessment, the new Triage NT-proBNP (N-terminal pro b-type natriuretic peptide) test is a useful biomarker in the diagnosis and management of patients with heart failure (HF) its manufacturer Alere International reports.
Prior to October’s 3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry in Salzburg, Austria, laboratory experts conveyed their opinions in an interview with Michael Krassnitzer from European Hospital.
Scientists from the Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research (ICR) built on earlier genome-wide research to link a genetic change associated with prostate cancer risk to a significant reduction in the amount of a protein called microseminoprotein-beta (MSMB). The protein - which regulates prostate cell death - is produced by normal prostate cells –…
On 4 October, the waste reservoir of an aluminium factory in Hungary burst. Red sludge, which is the waste resulting from the production of aluminium, flooded nearby villages. In the second week of October, researchers were granted access to the area. Doctoral student Stefan Ruyters and postdoctoral researcher Jelle Mertens of the Division of Soil and Water Management (Faculty of Bioengineering)…
Detection of circulating and disseminated tumour cells in blood is a promising method to diagnose cancer dissemination, or to follow up cancer patients during therapy. Today’s methods and involve time-consuming (more than a day) sample processing and cell isolation steps -- all labour intensive and expensive. A lab-on-chip that could integrate those processing steps would enable faster,…
Biomarkers as the key to prevention and early detection were the subject this autumn at the 7th Annual Congress of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) in Mannheim. For the DGKL president Professor Karl J Lackner MD, Director of the Institute for Clinical Chemistry and Laboratory Medicine at Johannes Gutenberg University, Mainz, the topic is of increasing…
Small and with a life cycle of just two weeks, fruit flies are seen by many as pests and a problem all year round. However, for nearly a century, the humble insect, officially known as Drosophila melanogaster, which measures no more than 3mm, has performed a vital role in genetics and developmental biology. Fruit flies are genetically diverse and easy to use in research, helping scientists in a…
Ikerlan-IK4 and Mondragón Unibertsitatea are taking part in a project initiated by the Spanish National Research Council, CSIC, and which has developed a microchip capable of separating and extracting tumour cells in the blood stream by means of ultrasonic waves. The Foundation General Hospital of the University of Elche, together with researcher Alfredo Carrato, has also collaborated on this…
Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.